Switching from Nitrate Therapy to Ranolazine in Patients with Coronary Artery Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction

Coronary artery disease (CAD) and erectile dysfunction (ED) frequently coexist. The introduction of phosphodiesterase type-5 (PDE-5) inhibitors has revolutionized medical management of organic ED; however, in patients with angina pectoris, a common symptom of CAD, coadministration of PDE-5 inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Udeoji, Dioma U, Schwarz, Ernst R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238423/
https://www.ncbi.nlm.nih.gov/pubmed/25452706
http://dx.doi.org/10.4137/CCRep.S16915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238423/
https://www.ncbi.nlm.nih.gov/pubmed/25452706
http://dx.doi.org/10.4137/CCRep.S16915

Ejemplares similares